A detailed history of Dfpg Investments, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Dfpg Investments, LLC holds 31,219 shares of ABBV stock, worth $5.62 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
31,219
Previous 30,590 2.06%
Holding current value
$5.62 Million
Previous $4.56 Million 6.12%
% of portfolio
0.37%
Previous 0.43%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 09, 2024

BUY
$137.6 - $154.97 $86,550 - $97,476
629 Added 2.06%
31,219 $4.84 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $370,712 - $429,153
2,775 Added 9.98%
30,590 $4.56 Million
Q2 2023

Jul 24, 2023

BUY
$132.51 - $164.9 $265,682 - $330,624
2,005 Added 7.77%
27,815 $3.75 Million
Q1 2023

Apr 10, 2023

SELL
$144.61 - $166.54 $222,265 - $255,971
-1,537 Reduced 5.62%
25,810 $4.11 Million
Q4 2022

Feb 02, 2023

BUY
$138.31 - $165.87 $1.51 Million - $1.81 Million
10,899 Added 66.26%
27,347 $4.42 Million
Q3 2022

Oct 24, 2022

BUY
$134.21 - $153.93 $157,696 - $180,867
1,175 Added 7.69%
16,448 $2.42 Million
Q2 2022

Aug 01, 2022

SELL
$137.62 - $174.96 $15,963 - $20,295
-116 Reduced 0.75%
15,273 $2.28 Million
Q1 2022

Apr 22, 2022

SELL
$131.98 - $163.75 $37,218 - $46,177
-282 Reduced 1.8%
15,389 $2.45 Million
Q4 2021

Jan 31, 2022

SELL
$107.43 - $135.93 $117,958 - $149,251
-1,098 Reduced 6.55%
15,671 $2.09 Million
Q3 2021

Oct 19, 2021

BUY
$106.4 - $120.78 $46,603 - $52,901
438 Added 2.68%
16,769 $1.83 Million
Q2 2021

Jul 21, 2021

BUY
$105.21 - $117.21 $154,343 - $171,947
1,467 Added 9.87%
16,331 $1.93 Million
Q1 2021

Apr 14, 2021

BUY
$102.3 - $112.62 $96,571 - $106,313
944 Added 6.78%
14,864 $1.58 Million
Q4 2020

Jan 19, 2021

BUY
$80.49 - $108.67 $1.12 Million - $1.51 Million
13,920 New
13,920 $1.49 Million
Q4 2019

Feb 04, 2020

SELL
$72.13 - $90.25 $1.28 Million - $1.6 Million
-17,753 Closed
0 $0
Q3 2019

Oct 15, 2019

BUY
$62.98 - $75.72 $1.12 Million - $1.34 Million
17,753 New
17,753 $1.31 Million
Q2 2019

Jul 30, 2019

SELL
$65.7 - $83.98 $205,575 - $262,773
-3,129 Closed
0 $0
Q1 2019

Apr 10, 2019

BUY
$77.14 - $90.79 $2,777 - $3,268
36 Added 1.16%
3,129 $259,000
Q4 2018

Jan 22, 2019

BUY
$77.85 - $96.01 $240,790 - $296,958
3,093 New
3,093 $285,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Dfpg Investments, LLC Portfolio

Follow Dfpg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dfpg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dfpg Investments, LLC with notifications on news.